Reckitt Benckiser (Australia) - Scholl nail treatment solution

Therapeutic Goods Act 1989

Approval under section 42DF for use of a restricted representation by Reckitt Benckiser (Australia) Pty Limited

I, Dr Jane Cook, Head, Office of Product Review, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health, on receipt of an application by Reckitt Benckiser (Australia) Pty Limited, have approved under section 42DF (1) of the Therapeutic Goods Act 1989 (the Act) the restricted representations described in paragraph (a) below for use on the label and in advertisements directed to consumers, for the products identified in paragraph (b):

1. "Diabetes" and "Diabetic" when used solely in the context of the cautionary statement: "Please SEEK ADVICE before using this product if you are Diabetic as your foot condition may require treatment by a healthcare professional" accompanied by the alert box "Scholl and diabetes".
2. Scholl 'Nail treatment solution' products included in ARTG 219480.

Dated this 26 day of March 2014.

Dr Jane Cook
Delegate of the Secretary to the Department of Health; and
Office Head
Office of Product Review